Article Text

Download PDFPDF
AB0103 Tacrolimus Inhibit IL-1β and ER Stress-Induced, Rankl-Mediated Osteoclastogenesis by Inhibiting Perk, Ire1, Grp78, Eif2a, C-Fos and Nfatc1
  1. W.-S. Lee1,
  2. E.-G. Lee1,
  3. M.-S. Sung1,
  4. C.-H. Lee2,
  5. M.-S. Lee2,
  6. W.-H. Yoo1
  1. 1Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University Hospital-Chonbuk National University, jeonju
  2. 2Department of Internal Medicine, School of medicine, Wonkwang university, Iksan, Korea, Republic Of


Background Tacrolimus (TAC) is a T cell specific, anti-inflammatory agent that has been used as a therapeutic agent for rheumatoid arthritis (RA). IL-1β and thapsigargin (TG)-induced endoplasmic reticulum (ER) stress modulate the receptor activator of nuclear factor kappa-B ligand (RANKL)-mediated osteoclastogenesis.

Objectives This study was investigated to define the effects of TAC on IL-1β and ER stress-induced, RANKL-mediated osteoclastogenesis and its mechanisms.

Methods Bone marrow cells (BMCs) were obtained from 5-week-old male ICR mice and cultured to be differentiated into osteoclasts with M-CSF and RANKL in the presence or absence of IL-1β, TG, or TAC. The formation of osteoclasts was evaluated by tartrate-resistant acid phosphatase (TRAP) staining and resorption pit assay with dentine slice. The molecular mechanisms of the above effects of TAC on osteoclastogenesis were investigated by using RT-PCR and immunoblotting for osteoclast specific and ER stress signaling molecules, including PERK, IRE1, GRP78, eIF2α, c-Fos and NFATc1.

Results IL-1β and TG-induced ER stress increased the formation of osteoclasts by up-regulating the osteoclast specific signals (c-Fos, NFATc1) and ER stress-associated signaling pathways (PERK, IRE1, GRP78, and eIF2α). TAC significantly inhibited IL-1β and ER stress-induced, RANKL-mediated osteoclastogenesis by down-regulating above signal pathways, dose-dependently.

Conclusions TAC inhibited IL-1β and ER stress-induced, RANKL-mediated osteoclastogenesis by inhibiting intracellular signaling pathways, including PERK, IRE1, GRP78, c-Fos and NFATc1. These results suggest that TAC might have disease modifying effects by inhibition of inflammation and ER stress-induced osteoclastogenesis in the inflammatory joint diseases, such as RA.

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.4216

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.